| __timestamp | Axsome Therapeutics, Inc. | MorphoSys AG |
|---|---|---|
| Wednesday, January 1, 2014 | 1392830 | 9689000 |
| Thursday, January 1, 2015 | 2419289 | 10431000 |
| Friday, January 1, 2016 | 6343648 | 9618000 |
| Sunday, January 1, 2017 | 7206691 | 12348000 |
| Monday, January 1, 2018 | 9351522 | 28310241 |
| Tuesday, January 1, 2019 | 13598030 | 59336147 |
| Wednesday, January 1, 2020 | 28896749 | 159145941 |
| Friday, January 1, 2021 | 66646205 | 199800000 |
| Saturday, January 1, 2022 | 159253661 | 90225000 |
| Sunday, January 1, 2023 | 323123000 | 92538000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, managing operational costs is crucial for success. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Axsome Therapeutics, Inc. and MorphoSys AG from 2014 to 2023. Over this period, Axsome Therapeutics saw a staggering increase in SG&A expenses, growing by over 23,000% from 2014 to 2023. In contrast, MorphoSys AG experienced a more modest growth of approximately 855% during the same timeframe.
This comparison highlights the diverse strategies employed by biotech firms in navigating the financial landscape.
Operational Costs Compared: SG&A Analysis of Eli Lilly and Company and Axsome Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Novo Nordisk A/S or MorphoSys AG
SG&A Efficiency Analysis: Comparing Insmed Incorporated and MorphoSys AG
Operational Costs Compared: SG&A Analysis of Blueprint Medicines Corporation and Axsome Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Grifols, S.A. and MorphoSys AG
Comparing SG&A Expenses: Corcept Therapeutics Incorporated vs MorphoSys AG Trends and Insights
Alkermes plc and MorphoSys AG: SG&A Spending Patterns Compared
Axsome Therapeutics, Inc. or Perrigo Company plc: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Axsome Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated
Breaking Down SG&A Expenses: Axsome Therapeutics, Inc. vs Taro Pharmaceutical Industries Ltd.
Operational Costs Compared: SG&A Analysis of MorphoSys AG and Amicus Therapeutics, Inc.
Who Optimizes SG&A Costs Better? MorphoSys AG or Taro Pharmaceutical Industries Ltd.